(HealthDay)—A new fluid protocol is safe and effective in preventing contrast-induced acute kidney injury in patients undergoing cardiac catheterization, according to a study published in the May 24 issue of The Lancet.
Somjot S. Brar, M.D., from Kaiser Permanente in Los Angeles, and colleagues conducted a phase 3 trial involving 396 adult undergoing cardiac catheterization (with an estimated glomerular filtration rate of ≤60 mL/min/1.73 m² and one or more of several risk factors). Patients were randomized (1:1) to either left ventricular end-diastolic pressure-guided volume expansion (196 participants) or a control group where they received a standard fluid administration protocol (200 participants).
The researchers found that contrast-induced acute kidney injury occurred less frequently in patients in the left ventricular end-diastolic pressure-guided group (6.7 percent versus 16.3 percent in the control group; relative risk, 0.41; P = 0.005). Shortness of breath occurred in three patients in each group, requiring hydration treatment to be prematurely terminated.
"Left ventricular end-diastolic pressure-guided fluid administration seems to be safe and effective in preventing contrast-induced acute kidney injury in patients undergoing cardiac catheterization," the authors write.
Explore further: Hydration based on ventricular pressure is effective in reducing kidney damage in patients undergoing cardiac catheteriz
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)